Cargando…
Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism
Pituitary-dependent hyperadrenocorticism (PDH) is mainly caused by pituitary corticotroph tumors in dogs. A characteristic feature of corticotroph tumors is their resistance to negative feedback by glucocorticoids. In some animal species, including dogs, the aberrant expression of 11β-hydroxysteroid...
Autores principales: | Teshima, Takahiro, Matsumoto, Hirotaka, Okusa, Tomoko, Uchiyama, Rion, Koyama, Hidekazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100902/ https://www.ncbi.nlm.nih.gov/pubmed/27824928 http://dx.doi.org/10.1371/journal.pone.0166267 |
Ejemplares similares
-
Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis
por: Teshima, Takahiro, et al.
Publicado: (2015) -
Serum Cortisol Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism and Atypical Hyperadrenocorticism
por: Frank, L.A., et al.
Publicado: (2014) -
Three Cases of Transtracheal Catheter Oxygenation for Postoperative Dyspnoea with Pituitary-Dependent Hyperadrenocorticism in Dogs Treated by Surgery
por: Tanaka, Sachiyo, et al.
Publicado: (2022) -
Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020) -
Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion
por: Teshima, Takahiro, et al.
Publicado: (2018)